Træk
Excessive sweating
Klinisk navn: Hyperhidrosis
Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.
Resumé
- Også kaldet
- Increased sweating, Profuse sweating, Sweating, Sweating profusely, Sweating, increased, Diaphoresis
- Kropssystem
- Abnormality of the integument
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Excessive sweating, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test137 gener knyttet til Excessive sweating
Ændringer i disse gener forårsager sjældne tilstande, hvor Excessive sweating ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| BOLA3bolA family member 3 | Altid | I 1 tilstand |
| DSG1desmoglein 1 | Altid | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Altid | I 1 tilstand |
| LIFRLIF receptor subunit alpha | Altid | I 2 tilstande |
| MAP2K1mitogen-activated protein kinase kinase 1 | Altid | I 2 tilstande |
| MAP2K2mitogen-activated protein kinase kinase 2 | Altid | I 2 tilstande |
| SHQ1SHQ1, H/ACA ribonucleoprotein assembly factor | Altid | I 1 tilstand |
| SLC18A2solute carrier family 18 member A2 | Altid | I 2 tilstande |
| SUCLG1succinate-CoA ligase GDP/ADP-forming subunit alpha | Altid | I 2 tilstande |
| AIPAHR interacting HSP90 co-chaperone | Meget ofte (80–99 %) | I 2 tilstande |
| AQP5aquaporin 5 | Meget ofte (80–99 %) | I 1 tilstand |
| BCL10BCL10 immune signaling adaptor | Meget ofte (80–99 %) | I 1 tilstand |
| BIRC3baculoviral IAP repeat containing 3 | Meget ofte (80–99 %) | I 1 tilstand |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Meget ofte (80–99 %) | I 2 tilstande |
| CACNA1Scalcium voltage-gated channel subunit alpha1 S | Meget ofte (80–99 %) | I 1 tilstand |
| CLCF1cardiotrophin like cytokine factor 1 | Meget ofte (80–99 %) | I 1 tilstand |
| CRLF1cytokine receptor like factor 1 | Meget ofte (80–99 %) | I 2 tilstande |
| ELP1elongator acetyltransferase complex subunit 1 | Meget ofte (80–99 %) | I 1 tilstand |
| FOXP1forkhead box P1 | Meget ofte (80–99 %) | I 1 tilstand |
| FUCA1alpha-L-fucosidase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| GABRA3gamma-aminobutyric acid type A receptor subunit alpha3 | Meget ofte (80–99 %) | I 1 tilstand |
| GPR101G protein-coupled receptor 101 | Meget ofte (80–99 %) | I 2 tilstande |
| HNF4Ahepatocyte nuclear factor 4 alpha | Meget ofte (80–99 %) | I 1 tilstand |
| HPGD15-hydroxyprostaglandin dehydrogenase | Meget ofte (80–99 %) | I 3 tilstande |
| IGHimmunoglobulin heavy locus | Meget ofte (80–99 %) | I 1 tilstand |
| KCNJ18potassium inwardly rectifying channel subfamily J member 18 | Meget ofte (80–99 %) | I 1 tilstand |
| KIF1Akinesin family member 1A | Meget ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Meget ofte (80–99 %) | I 1 tilstand |
| MALT1MALT1 paracaspase | Meget ofte (80–99 %) | I 1 tilstand |
| MEN1menin 1 | Meget ofte (80–99 %) | I 2 tilstande |
| NLRP3NLR family pyrin domain containing 3 | Meget ofte (80–99 %) | I 1 tilstand |
| PHOX2Bpaired like homeobox 2B | Meget ofte (80–99 %) | I 2 tilstande |
| RETREG1reticulophagy regulator 1 | Meget ofte (80–99 %) | I 1 tilstand |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Meget ofte (80–99 %) | I 2 tilstande |
| SERPINB7serpin family B member 7 | Meget ofte (80–99 %) | I 1 tilstand |
| SLCO2A1solute carrier organic anion transporter family member 2A1 | Meget ofte (80–99 %) | I 3 tilstande |
| WNK1WNK lysine deficient protein kinase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| YY1YY1 transcription factor | Meget ofte (80–99 %) | I 1 tilstand |
| ACDACD shelterin complex subunit and telomerase recruitment factor | Ofte (30–79 %) | I 1 tilstand |
| CDH23cadherin related 23 | Ofte (30–79 %) | I 1 tilstand |
Vis 97 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| CDKN2Acyclin dependent kinase inhibitor 2A | Ofte (30–79 %) | I 1 tilstand |
| CLCN6Cl-/H+ antiporter 6 | Ofte (30–79 %) | I 1 tilstand |
| CTC1CST telomere replication complex component 1 | Ofte (30–79 %) | I 1 tilstand |
| CTNNB1catenin beta 1 | Ofte (30–79 %) | I 1 tilstand |
| CTSHcathepsin H | Ofte (30–79 %) | I 1 tilstand |
| DDCdopa decarboxylase | Ofte (30–79 %) | I 2 tilstande |
| DKC1dyskerin pseudouridine synthase 1 | Ofte (30–79 %) | I 2 tilstande |
| DSTdystonin | Ofte (30–79 %) | I 1 tilstand |
| FGFR2fibroblast growth factor receptor 2 | Ofte (30–79 %) | I 2 tilstande |
| FLRT1fibronectin leucine rich transmembrane protein 1 | Ofte (30–79 %) | I 1 tilstand |
| GNA14G protein subunit alpha 14 | Ofte (30–79 %) | I 2 tilstande |
| HCRThypocretin neuropeptide precursor | Ofte (30–79 %) | I 1 tilstand |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Ofte (30–79 %) | I 1 tilstand |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Ofte (30–79 %) | I 2 tilstande |
| JAK2Janus kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| JUPjunction plakoglobin | Ofte (30–79 %) | I 1 tilstand |
| KCNA1potassium voltage-gated channel subfamily A member 1 | Ofte (30–79 %) | I 1 tilstand |
| KLC2kinesin light chain 2 | Ofte (30–79 %) | I 2 tilstande |
| MOGmyelin oligodendrocyte glycoprotein | Ofte (30–79 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Ofte (30–79 %) | I 1 tilstand |
| NGLY1N-glycanase 1 | Ofte (30–79 %) | I 1 tilstand |
| NHP2NHP2 ribonucleoprotein | Ofte (30–79 %) | I 1 tilstand |
| NOP10NOP10 ribonucleoprotein | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| P2RY11purinergic receptor P2Y11 | Ofte (30–79 %) | I 1 tilstand |
| PARNpoly(A)-specific ribonuclease | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| PRNPprion protein (Kanno blood group) | Ofte (30–79 %) | I 2 tilstande |
| RTEL1regulator of telomere elongation helicase 1 | Ofte (30–79 %) | I 1 tilstand |
| SLC16A2solute carrier family 16 member 2 | Ofte (30–79 %) | I 1 tilstand |
| SLURP1secreted LY6/PLAUR domain containing 1 | Ofte (30–79 %) | I 2 tilstande |
| SPRsepiapterin reductase | Ofte (30–79 %) | I 1 tilstand |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Ofte (30–79 %) | I 1 tilstand |
| TATtyrosine aminotransferase | Ofte (30–79 %) | I 1 tilstand |
| TERCtelomerase RNA component | Ofte (30–79 %) | I 1 tilstand |
| TERTtelomerase reverse transcriptase | Ofte (30–79 %) | I 2 tilstande |
| THPOthrombopoietin | Ofte (30–79 %) | I 1 tilstand |
| TINF2TERF1 interacting nuclear factor 2 | Ofte (30–79 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Ofte (30–79 %) | I 1 tilstand |
| TP53tumor protein p53 | Ofte (30–79 %) | I 1 tilstand |
| TRANK1tetratricopeptide repeat and ankyrin repeat containing 1 | Ofte (30–79 %) | I 1 tilstand |
| TYMSthymidylate synthetase | Ofte (30–79 %) | I 1 tilstand |
| USB1U6 snRNA biogenesis phosphodiesterase 1 | Ofte (30–79 %) | I 1 tilstand |
| WRAP53WD repeat containing antisense to TP53 | Ofte (30–79 %) | I 1 tilstand |
| ZNF365zinc finger protein 365 | Ofte (30–79 %) | I 1 tilstand |
| ZNRF3zinc and ring finger 3 | Ofte (30–79 %) | I 1 tilstand |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Nogle gange (5–29 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Nogle gange (5–29 %) | I 1 tilstand |
| CCND1cyclin D1 | Nogle gange (5–29 %) | I 1 tilstand |
| CNBPCCHC-type zinc finger nucleic acid binding protein | Nogle gange (5–29 %) | I 1 tilstand |
| COL17A1collagen type XVII alpha 1 chain | Nogle gange (5–29 %) | I 1 tilstand |
| CTSBcathepsin B | Nogle gange (5–29 %) | I 1 tilstand |
| CUL4Bcullin 4B | Nogle gange (5–29 %) | I 1 tilstand |
| FBXO11F-box protein 11 | Nogle gange (5–29 %) | I 1 tilstand |
| GRB10growth factor receptor bound protein 10 | Nogle gange (5–29 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Nogle gange (5–29 %) | I 1 tilstand |
| HNRNPKheterogeneous nuclear ribonucleoprotein K | Nogle gange (5–29 %) | I 2 tilstande |
| KRT1keratin 1 | Nogle gange (5–29 %) | I 1 tilstand |
| KRT14keratin 14 | Nogle gange (5–29 %) | I 1 tilstand |
| KRT16keratin 16 | Nogle gange (5–29 %) | I 1 tilstand |
| KRT5keratin 5 | Nogle gange (5–29 %) | I 1 tilstand |
| KRT9keratin 9 | Nogle gange (5–29 %) | I 1 tilstand |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Nogle gange (5–29 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Nogle gange (5–29 %) | I 1 tilstand |
| PLAAphospholipase A2 activating protein | Nogle gange (5–29 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Nogle gange (5–29 %) | I 1 tilstand |
| RHOBTB2Rho related BTB domain containing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC2A1solute carrier family 2 member 1 | Nogle gange (5–29 %) | I 1 tilstand |
| SLC39A14solute carrier family 39 member 14 | Nogle gange (5–29 %) | I 1 tilstand |
| SPRED2sprouty related EVH1 domain containing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| TRPV3transient receptor potential cation channel subfamily V member 3 | Nogle gange (5–29 %) | I 1 tilstand |
| VHLvon Hippel-Lindau tumor suppressor | Nogle gange (5–29 %) | I 2 tilstande |
| WNT10AWnt family member 10A | Nogle gange (5–29 %) | I 1 tilstand |
| CLCNKBchloride voltage-gated channel Kb | Sjældent (1–4%) | I 1 tilstand |
| GLAgalactosidase alpha | Sjældent (1–4%) | I 1 tilstand |
| H19H19 imprinted maternally expressed transcript | Sjældent (1–4%) | I 1 tilstand |
| HINT1histidine triad nucleotide binding protein 1 | Sjældent (1–4%) | I 2 tilstande |
| HMBShydroxymethylbilane synthase | Sjældent (1–4%) | I 1 tilstand |
| HRASHRas proto-oncogene, GTPase | Sjældent (1–4%) | I 1 tilstand |
| IGF2insulin like growth factor 2 | Sjældent (1–4%) | I 1 tilstand |
| NTRK1neurotrophic receptor tyrosine kinase 1 | Sjældent (1–4%) | I 1 tilstand |
| SLC12A3solute carrier family 12 member 3 | Sjældent (1–4%) | I 1 tilstand |
| COL6A1collagen type VI alpha 1 chain | Ikke registreret | I 1 tilstand |
| HEXBhexosaminidase subunit beta | Ikke registreret | I 1 tilstand |
| IGHMBP2immunoglobulin mu DNA binding protein 2 | Ikke registreret | I 1 tilstand |
| KIF1Bkinesin family member 1B | Ikke registreret | I 1 tilstand |
| KRT6Akeratin 6A | Ikke registreret | I 1 tilstand |
| MAXMYC associated transcriptional regulator X | Ikke registreret | I 1 tilstand |
| RETret proto-oncogene | Ikke registreret | I 1 tilstand |
| SCN11Asodium voltage-gated channel alpha subunit 11 | Ikke registreret | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Ikke registreret | I 1 tilstand |
| SDHCsuccinate dehydrogenase complex subunit C | Ikke registreret | I 1 tilstand |
| SDHDsuccinate dehydrogenase complex subunit D | Ikke registreret | I 1 tilstand |
| TMEM127transmembrane protein 127 | Ikke registreret | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Snævrere træk
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger